Early research (Phase 1)Study completedNCT01509846What this trial is testingSafety Study of Inactivated Shigella Whole Cell Vaccine in AdultsWho this might be right forShigellosis PATH 82
Large-scale testing (Phase 3)Active Not RecruitingNCT06838195What this trial is testingClinical Trial of the S. Flexneri-S. Sonnei Bivalent Conjugate VaccineWho this might be right forDysenteryDysentery, Shigella Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 8,000
Testing effectiveness (Phase 2)Study completedNCT00485134What this trial is testingShigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of ProtectionWho this might be right forShigellosis U.S. Army Medical Research and Development Command 113
Early research (Phase 1)Study completedNCT02034500What this trial is testingEvaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy AdultsWho this might be right forShigellosis GSK Vaccines Institute For Global Health S.r.l. 52
Not applicableUnknownNCT03778125What this trial is testingMultidrug Resistant Shigella Infection in BangladeshWho this might be right forDiarrheaShigella University of Virginia 2,000
Large-scale testing (Phase 3)Study completedNCT00368316What this trial is testingSafety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in IsraelWho this might be right forShigellosis Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 2,799
Testing effectiveness (Phase 2)Study completedNCT04056117What this trial is testingDetermine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan InfantsWho this might be right forShigellosis LimmaTech Biologics AG 597
Early research (Phase 1)Study completedNCT04992520What this trial is testingControlled Human Infection Model Challenge/RechallengeWho this might be right forShigellosis PATH 46
Testing effectiveness (Phase 2)WithdrawnNCT03038243What this trial is testingSafety, Immunogenicity and Efficacy Study of Inactivated Whole Cell Shigella Flexneri 2a Vaccine With and Without dmLT in AdultsWho this might be right forShigella Sonnei Dysenteries PATH
Early research (Phase 1)Study completedNCT01369927What this trial is testingShigella Sonnel O-SPC/rBRU Conjugate VaccineWho this might be right forImmunogenicityShigellosis Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 60
Early research (Phase 1)Study completedNCT04634513What this trial is testingShigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122Who this might be right forShigella InfectionEnterotoxigenic Escherichia Coli Infection University of Maryland, Baltimore 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT05182749What this trial is testingSafety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of ShigellosisWho this might be right forShigellosis Intralytix, Inc. 52
Testing effectiveness (Phase 2)Study completedNCT06663436What this trial is testingA Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in InfantsWho this might be right forDiarrhoea GlaxoSmithKline 200
Testing effectiveness (Phase 2)Study completedNCT02646371What this trial is testingPhase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2aWho this might be right forShigellosis LimmaTech Biologics AG 67
Testing effectiveness (Phase 2)Study completedNCT02676895What this trial is testingThe Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan AdultsWho this might be right forShigella Sonnei Infection GlaxoSmithKline 74
Early research (Phase 1)Study completedNCT02816346What this trial is testingDose-Finding Study of Lyophilized Shigella Sonnei 53G Challenge StrainWho this might be right forHealthy PATH 56
Large-scale testing (Phase 3)UnknownNCT05156528What this trial is testingEfficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 YearsWho this might be right forDysenteryShigellosis Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 21,000
Testing effectiveness (Phase 2)Ended earlyNCT00866476What this trial is testingSafety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIaWho this might be right forShigella University of Maryland, Baltimore 20
Early research (Phase 1)Looking for participantsNCT05961059What this trial is testingInvaplexAR-Detox and DmLT Adjuvant in the Netherlands and ZambiaWho this might be right forShigellosisBacillary Dysentery Leiden University Medical Center 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT06615375What this trial is testingA Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate VaccineWho this might be right forShigellosis LimmaTech Biologics AG 120